BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 18275645)

  • 1. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
    Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
    JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant cervical intraepithelial neoplasia?
    Matthews KS; Rocconi RP; Case AS; Estes JM; Straughn JM; Huh WK
    J Low Genit Tract Dis; 2007 Apr; 11(2):69-72. PubMed ID: 17415109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
    Numnum TM; Kirby TO; Leath CA; Huh WK; Alvarez RD; Straughn JM
    J Low Genit Tract Dis; 2005 Jan; 9(1):2-6. PubMed ID: 15870514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
    Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S78-84. PubMed ID: 23519309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population.
    Adam Y; van Gelderen CJ; de Bruyn G; McIntyre JA; Turton DA; Martinson NA
    BMC Cancer; 2008 Jul; 8():211. PubMed ID: 18657270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
    Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
    Keller MJ; Burk RD; Massad LS; Eltoum IE; Hessol NA; Castle PE; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Levine AM; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
    Clin Infect Dis; 2015 Nov; 61(10):1573-81. PubMed ID: 26187020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
    Vale DB; Westin MC; Zeferino LC
    Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of cervical intraepithelial neoplasia grade II or worse in women with a persistent low-grade squamous intraepithelial lesion seen by Papanicolaou smears.
    Nogara PR; Manfroni LA; Consolaro ME
    Arch Gynecol Obstet; 2013 Nov; 288(5):1125-30. PubMed ID: 23644924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
    Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
    Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
    Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.
    Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH
    Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting.
    Mangclaviraj S; Kerr SJ; Chaithongwongwatthana S; Ananworanich J; Hirschel B; Emery S; Cooper DA; Chotnopparatpattara P; Ruxrungtham K; Phanuphak P
    Int J STD AIDS; 2008 Aug; 19(8):529-32. PubMed ID: 18663038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY; Feng YK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.
    Greene SA; De Vuyst H; John-Stewart GC; Richardson BA; McGrath CJ; Marson KG; Trinh TT; Yatich N; Kiptinness C; Cagle A; Nyongesa-Malava E; Sakr SR; Mugo NR; Chung MH
    JAMA; 2019 Oct; 322(16):1570-1579. PubMed ID: 31638680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical dysplasia and human immunodeficiency virus infection in women: prevalence and associated factors. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GESCA).
    Hocke C; Leroy V; Morlat P; Rivel J; Duluc MC; Boulogne N; Tandonnet B; Dupon M; Brun JL; Dabis F
    Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 81(1):69-76. PubMed ID: 9846718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.